bioAffinity Technologies (BIAF) Gross Margin (2022 - 2025)
bioAffinity Technologies (BIAF) posted quarterly Gross Margin of 43.49% for Q4 2025, up 1425.0% year-over-year from 2.85% in Q4 2024, and up 24.81% quarter-over-quarter from 34.84% in Q3 2025.
bioAffinity Technologies (BIAF) Gross Margin (2022 - 2025) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Gross Margin for 4 consecutive years, with 43.49% the latest figure, recorded in Q4 2025.
- In Q4 2025, Gross Margin rose 1425.0% year-over-year to 43.49%; the TTM figure through Dec 2025 stood at 31.4% (down 468.0% YoY), while the FY2025 annual figure was 31.4%, down 468.0% from the prior year.
- Gross Margin climbed to 43.49% in Q4 2025 per BIAF's latest filing, from 34.84% in the prior quarter.
- Across five years, Gross Margin topped out at 93.75% in Q2 2023 and bottomed at 19.92% in Q2 2025.
- Historically, Gross Margin has averaged 54.74% across 4 years, with a median of 41.29% in 2024.
- Annual changes were most pronounced in 2023 — Gross Margin tumbled 6776 bps — and 2025, when it jumped 1425 bps.
- bioAffinity Technologies' Gross Margin stood at 92.54% in 2022, then tumbled by 73 bps to 24.78% in 2023, then grew by 18 bps to 29.24% in 2024, then soared by 49 bps to 43.49% in 2025.
- Business Quant data shows BIAF's Gross Margin at 43.49% in Q4 2025, 34.84% in Q3 2025, and 19.92% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 69.57% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 57.64% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 64.04% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 53.95% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 32.85% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 99.91% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 66.44% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 63.29% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 33.75% |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43.49% |
| Sep 30, 2025 | 34.84% |
| Jun 30, 2025 | 19.92% |
| Mar 31, 2025 | 26.21% |
| Dec 31, 2024 | 29.24% |
| Sep 30, 2024 | 38.73% |
| Jun 30, 2024 | 41.29% |
| Mar 31, 2024 | 34.61% |
| Dec 31, 2023 | 24.78% |
| Sep 30, 2023 | 74.97% |
| Jun 30, 2023 | 93.75% |
| Mar 31, 2023 | 90.55% |
| Dec 31, 2022 | 92.54% |
| Sep 30, 2022 | 87.30% |
| Jun 30, 2022 | 88.82% |